Nanjing, Jiangsu Province-based Simcere Pharmaceutical Group says it has entered into a definitive agreement for a management buyout led by its founder Ren Jinsheng for around $490 million. The buyer is a consortium headed by Simcere's founder Ren Jinsheng. Simcere's current CEO Liu Hongquan and Beijing-based private equity firm Hony Capital are also participating in […]

Visit ChinaMoneyNetwork.com for more great China Money Podcast audio and video Internet episodes covering important investment news and financial events in China, as well as daily news updates on important China business news happenings. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.